Differential Involvement of P-Glycoprotein (ABCB1) in Permeability, Tissue Distribution, and Antinociceptive Activity of Methadone, Buprenorphine, and DIPRENORPHINE (cas 14357-78-9): In Vitro and In Vivo Evaluation
-
Add time:08/08/2019 Source:sciencedirect.com
Conclusions based on either in vitro or in vivo approach to evaluate the P-gp affinity status of opioids may be misleading. For example, in vitro studies indicated that fentanyl is a P-gp inhibitor while in vivo studies indicated that it is a P-gp substrate. Quite the opposite was evident for meperidine. The objective of this study was to evaluate the P-gp affinity status of methadone, buprenorphine and diprenorphine to predict P-gp-mediated drug-drug interactions and to determine a better candidate for management of opioid dependence. Two in vitro (P-gp ATPase and monolayer efflux) assays and two in vivo (tissue distribution and antinociceptive evaluation in mdr1a/b (−/−) mice) assays were used. Methadone stimulated the P-gp ATPase activity only at higher concentrations, while verapamil and GF120918 inhibited its efflux (p < 0.05). The brain distribution and antinociceptive activity of methadone were enhanced (p < 0.05) in P-gp knockout mice. Conversely, buprenorphine and diprenorphine were negative in all assays. P-gp can affect the PK/PD of methadone, but not buprenorphine or diprenorphine. Our report is in favor of buprenorphine over methadone for management of opioid dependence. Buprenorphine most likely is not a P-gp substrate and concerns regarding P-gp-mediated drug-drug interaction are not expected. © 2009 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:4928–4940, 2009
We also recommend Trading Suppliers and Manufacturers of DIPRENORPHINE (cas 14357-78-9). Pls Click Website Link as below: cas 14357-78-9 suppliers
Prev:Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: An [11C]DIPRENORPHINE (cas 14357-78-9) PET study
Next:Different Types of Steroids Inhibit [3H]DIPRENORPHINE (cas 14357-78-9) Binding in Mouse Brain Membranes) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- DIPRENORPHINE (cas 14357-78-9) as a stimulus in drug discrimination learning08/11/2019
- [3H]DIPRENORPHINE (cas 14357-78-9) receptor binding in vivo and in vitro08/10/2019
- Different Types of Steroids Inhibit [3H]DIPRENORPHINE (cas 14357-78-9) Binding in Mouse Brain Membranes08/09/2019
- Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: An [11C]DIPRENORPHINE (cas 14357-78-9) PET study08/07/2019
- Morphine and DIPRENORPHINE (cas 14357-78-9) together potentiate intake of alcoholic beverages08/06/2019
- Characterization of [3H]-DIPRENORPHINE (cas 14357-78-9) binding in Rana pipiens08/05/2019
- Quantification of opioid receptor availability following spontaneous epileptic seizures: Correction of [11C]DIPRENORPHINE (cas 14357-78-9) PET data for the partial-volume effect08/04/2019
- A combined [11C]DIPRENORPHINE (cas 14357-78-9) PET study and fMRI study of acupuncture analgesia08/03/2019
- Synthesis and opioid receptor binding of indium (III) and [111In]-labeled macrocyclic conjugates of DIPRENORPHINE (cas 14357-78-9): novel ligands designed for imaging studies of peripheral opioid receptors08/02/2019


